Successful CD34+ cell mobilisation is predictive of a survival advantage to patients with myeloma undergoing peripheral blood stem cell transplantation.

被引:0
|
作者
Williams, CD [1 ]
Watts, MJ [1 ]
Sullivan, AM [1 ]
Leverett, D [1 ]
Linch, DC [1 ]
Goldstone, AH [1 ]
机构
[1] UCL HOSP, LONDON, ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:302 / 302
页数:1
相关论文
共 50 条
  • [21] Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation
    Oren Pasvolsky
    Curtis Marcoux
    Denái R. Milton
    Babar Pal
    Mark R. Tanner
    Qaiser Bashir
    Samer Srour
    Jaehyun Lee
    Neeraj Saini
    Paul Lin
    Jeremy Ramdial
    Yago Nieto
    Guilin Tang
    Yosra Aljawai
    Partow Kebriaei
    Melody R. Becnel
    Hans C. Lee
    Krina K. Patel
    Sheeba K. Thomas
    Robert Z. Orlowski
    Elizabeth J. Shpall
    Richard E. Champlin
    Muzaffar H. Qazilbash
    Blood Cancer Journal, 14 (1)
  • [22] An improved technique of CD34+ determination for peripheral progenitor cell transplantation.
    Bolwell, B
    Sreenan, J
    Tubbs, R
    Baucco, P
    Sandhaus, L
    Edinger, M
    Goormastic, M
    Koo, A
    Fishleder, A
    BLOOD, 1995, 86 (10) : 459 - 459
  • [23] Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    S K Sohn
    J G Kim
    D H Kim
    N Y Lee
    J S Suh
    K B Lee
    Bone Marrow Transplantation, 2003, 31 : 967 - 972
  • [24] CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACS device
    Després, D
    Flohr, T
    Uppenkamp, M
    Baldus, M
    Hoffmann, M
    Huber, C
    Derigs, HG
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (04): : 557 - 564
  • [25] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma:: a case controlled analysis
    Gandhi, MK
    Jestice, HK
    Scott, MA
    Bloxham, DM
    Bass, G
    Craig, JIO
    Marcus, RE
    BONE MARROW TRANSPLANTATION, 1999, 24 (04) : 369 - 375
  • [26] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis
    MK Gandhi
    HK Jestice
    MA Scott
    DM Bloxham
    G Bass
    JIO Craig
    RE Marcus
    Bone Marrow Transplantation, 1999, 24 : 369 - 375
  • [27] Impact of CD34+ cell dose on the outcome of 65 patients undergoing reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. Experience in a single institution in Spain
    Martinez-Barranco, P
    Gayoso, J
    Fores, R
    Bautista, G
    Ruiz, E
    Navarro, B
    Marco, JG
    Gil, S
    Regidor, C
    Sanjuan, I
    Cabrera, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S206 - S207
  • [28] CD34+selected autologous peripheral blood stem cell transplantation (CD34+/ASCT) for multiple sclerosis
    Carreras, E
    Saiz, A
    Marín, P
    Martínez, C
    Rovira, M
    Villamor, N
    Aymerich, M
    Lozano, M
    Fernández-Avilés, F
    Urbano-Ispizua, A
    Berenguer, J
    Arbizu, T
    Montserrat, E
    Graus, F
    BONE MARROW TRANSPLANTATION, 2003, 31 : S16 - S16
  • [29] Autologous CD34+selected peripheral blood stem cell transplantation (CD34+/PBSCT) for multiple sclerosis
    Carreras, E
    Saiz, A
    Graus, F
    Marín, P
    Martínez, C
    Rovira, M
    Urbano-Ispizua, A
    Arbizu, T
    Casanova, B
    Mercader, JM
    Mazzara, R
    Merino, A
    Tolosa, E
    Montserrat, E
    BLOOD, 1999, 94 (10) : 398B - 398B
  • [30] Feasibility and efficacy of peripheral blood progenitor cell mobilisation with pegfilgrastim for allogeneic stem cell transplantation.
    Kroschinsky, F
    Hoelig, K
    Ordemann, R
    Haack, A
    Poppe-Thiede, K
    Blechschmidt, M
    Rall, G
    Bornhaeuser, M
    Schleyer, E
    Rutt, C
    Ehninger, G
    BLOOD, 2004, 104 (11) : 333B - 333B